New dengue vaccine shows promise in japan trial
NCT ID NCT06741683
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 26 times
Summary
This study tested a dengue vaccine (TDV) in 187 healthy Japanese volunteers aged 4 to 60. Participants received two shots three months apart, and researchers checked how well the vaccine triggered an immune response against all four types of dengue virus. The goal is to see if the vaccine is safe and effective at preventing dengue fever.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DENGUE FEVER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
OKURA Otolaryngology Clinic
Toshima-ku, Tokyo, Japan
-
PS Clinic
Fukuoka, Fukuoka, Japan
-
Saitama City Hospital
Saitama-shi, Saitama, Japan
-
Sumida Hospital
Sumida-ku, Tokyo, Japan
-
Tamura Clinic
Tokyo, Japan
Conditions
Explore the condition pages connected to this study.